Search results
Showing 6496 to 6510 of 8314 results
Absorb Bioresorbable Vascular Scaffold system for coronary artery disease (MIB84)
NICE withdrew this medtech innovation briefing in November 2017 after the company stopped manufacturing Absorb because of low uptake. Some UK hospitals continue to use the technology in ongoing clinical studies.
This guideline has been updated and replaced by NICE guideline NG135.
This guideline has been updated and replaced by NICE guideline NG90.
This guidance has been updated and replaced by NICE guideline NG44.
This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).
This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).
This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).
This guidance has been updated and replaced by NICE guideline CG189.
Tuberculosis: identification and management in under-served groups (PH37)
This guideline has been updated and replaced by NICE guideline NG33.
This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).
Substance misuse interventions for vulnerable under 25s (PH4)
This guidance has been updated and replaced by NICE guideline NG64.
Sexually transmitted infections and under-18 conceptions: prevention (PH3)
This guidance has been updated and replaced by NICE guideline NG221.
This guidance has been updated and replaced by NICE guideline NG60.
HIV testing: increasing uptake in men who have sex with men (PH34)
This guideline has been updated and replaced by NICE guideline NG60.
This guideline has been updated and replaced by the NICE guideline on tobacco: preventing uptake, promoting quitting and treating dependence (NG209).